On July 7, 2022, Generon (Shanghai) Corporation Ltd. closed the transaction. Post the transaction, Sino Biopharmaceutical Limited and Yifan Pharmaceutical (Hong Kong) Co., Ltd. now hold 2.44% and 66.92% stakes in the company respectively.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 HKD | -2.60% |
|
-5.07% | -24.50% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.50% | 6.32B | |
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Generon Corporation Ltd. announced that it has received $70.000203 million in funding from Sino Biopharmaceutical Limited, Yifan Pharmaceutical (Hong Kong) Co., Ltd.